Uitti RJ - Search Results

1

Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.

Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. Koga S, et al. Among authors: uitti rj. Acta Neuropathol. 2018 Sep;136(3):389-404. doi: 10.1007/s00401-018-1878-z. Epub 2018 Jun 20. Acta Neuropathol. 2018. PMID: 29926172 Free PMC article.

2

Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.

Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Britton JW, et al. Among authors: uitti rj. Neurology. 1995 Mar;45(3 Pt 1):443-7. doi: 10.1212/wnl.45.3.443. Neurology. 1995. PMID: 7898693 Free article.

3

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.

Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Uitti RJ, et al. Neurology. 1993 Oct;43(10):1918-26. doi: 10.1212/wnl.43.10.1918. Neurology. 1993. PMID: 8413948

4

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.

Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. Ahlskog JE, et al. Among authors: uitti rj. Mov Disord. 1995 Sep;10(5):566-73. doi: 10.1002/mds.870100507. Mov Disord. 1995. PMID: 8552107

5

Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.

Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Ahlskog JE, et al. Among authors: uitti rj. Neurology. 1996 Mar;46(3):796-801. doi: 10.1212/wnl.46.3.796. Neurology. 1996. PMID: 8618686

6

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Uitti RJ, et al. Neurology. 1996 Jun;46(6):1551-6. doi: 10.1212/wnl.46.6.1551. Neurology. 1996. PMID: 8649547

7

Does levodopa therapy delay death in Parkinson's disease?

Uitti RJ, Ahlskog JE, Maraganore DM. Uitti RJ, et al. Mov Disord. 1996 May;11(3):343-4. Mov Disord. 1996. PMID: 8723162 No abstract available.

8

Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.

Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E. Ahlskog JE, et al. Among authors: uitti rj. J Neurol Sci. 1996 Mar;136(1-2):162-8. doi: 10.1016/0022-510x(95)00318-v. J Neurol Sci. 1996. PMID: 8815165

9

Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.

Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC. Graff-Radford NR, et al. Among authors: uitti rj. Mayo Clin Proc. 1997 Jun;72(6):495-504. doi: 10.4065/72.6.495. Mayo Clin Proc. 1997. PMID: 9179132 Clinical Trial.

10

Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease.

Finton MJ, Lucas JA, Graff-Radford NR, Uitti RJ. Finton MJ, et al. Among authors: uitti rj. J Clin Exp Neuropsychol. 1998 Apr;20(2):186-93. doi: 10.1076/jcen.20.2.186.1167. J Clin Exp Neuropsychol. 1998. PMID: 9777472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters